Latest Aquilo Capital Management, LLC Stock Portfolio
$103Million– No. of Holdings #13
Aquilo Capital Management, LLC Performance:
2024 Q2: -15.88%YTD: -4.62%2023: 16.2%
Performance for 2024 Q2 is -15.88%, and YTD is -4.62%, and 2023 is 16.2%.
About Aquilo Capital Management, LLC and 13F Hedge Fund Stock Holdings
Aquilo Capital Management, LLC is a hedge fund based in SAN FRANCISCO, CA. On 30-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $442.5 Millions. In it's latest 13F Holdings report, Aquilo Capital Management, LLC reported an equity portfolio of $103.7 Millions as of 30 Jun, 2024.
The top stock holdings of Aquilo Capital Management, LLC are ARWR, BPMC, ARVN. The fund has invested 22.8% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 11.9% of portfolio in BLUEPRINT MEDICINES CORP.
They significantly reduced their stock positions in MERUS N V (MRUS), BLUEPRINT MEDICINES CORP (BPMC) and SUTRO BIOPHARMA INC (STRO). Aquilo Capital Management, LLC opened new stock positions in BICYCLE THERAPEUTICS PLC (BCYC), ADICET BIO INC (ACET) and IMMATICS N.V. The fund showed a lot of confidence in some stocks as they added substantially to REPARE THERAPEUTICS INC (RPTX) and ARVINAS INC (ARVN).
The top stock holdings of Aquilo Capital Management, LLC are ARWR, BPMC, ARVN. The fund has invested 22.8% of it's portfolio in ARROWHEAD PHARMACEUTICALS IN and 11.9% of portfolio in BLUEPRINT MEDICINES CORP.
They significantly reduced their stock positions in MERUS N V (MRUS), BLUEPRINT MEDICINES CORP (BPMC) and SUTRO BIOPHARMA INC (STRO). Aquilo Capital Management, LLC opened new stock positions in BICYCLE THERAPEUTICS PLC (BCYC), ADICET BIO INC (ACET) and IMMATICS N.V. The fund showed a lot of confidence in some stocks as they added substantially to REPARE THERAPEUTICS INC (RPTX) and ARVINAS INC (ARVN).
Aquilo Capital Management, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Aquilo Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Aquilo Capital Management, LLC made a return of -15.88% in the last quarter. In trailing 12 months, it's portfolio return was 7.41%.
New Buys
| Ticker | $ Bought |
|---|---|
| bicycle therapeutics plc | 3,171,450 |
| adicet bio inc | 3,062,740 |
| immatics n.v | 2,324,000 |
New stocks bought by Aquilo Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| repare therapeutics inc | 51.11 |
| arvinas inc | 5.67 |
Additions to existing portfolio by Aquilo Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| merus n v | -41.94 |
| blueprint medicines corp | -37.09 |
| sutro biopharma inc | -34.58 |
| kymera therapeutics inc | -15.43 |
| silence therapeutics plc | -12.89 |
| precision biosciences inc | -0.94 |
Aquilo Capital Management, LLC reduced stake in above stock
Sold off
Sector Distribution
Aquilo Capital Management, LLC has about 88.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.6 |
| Others | 11.4 |
Market Cap. Distribution
Aquilo Capital Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 52.6 |
| SMALL-CAP | 24.3 |
| MICRO-CAP | 11.7 |
| UNALLOCATED | 11.4 |
Stocks belong to which Index?
About 70.5% of the stocks held by Aquilo Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 70.5 |
| Others | 29.5 |
Aquilo Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aquilo Capital Management, LLC
Aquilo Capital Management, LLC has 13 stocks in it's portfolio. About 92.7% of the portfolio is in top 10 stocks. RGNX proved to be the most loss making stock for the portfolio. MRUS was the most profitable stock for Aquilo Capital Management, LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACET | adicet bio inc | 2.95 | 2,531,190 | 3,062,740 | new | |||
| ARVN | arvinas inc | 11.00 | 428,766 | 11,413,800 | added | 5.67 | ||
| ARWR | arrowhead pharmaceuticals in | 22.76 | 908,474 | 23,611,200 | unchanged | 0.00 | ||
| BCYC | bicycle therapeutics plc | 3.06 | 156,692 | 3,171,450 | new | |||
| BPMC | blueprint medicines corp | 11.91 | 114,600 | 12,351,600 | reduced | -37.09 | ||
| DTIL | precision biosciences inc | 3.58 | 381,803 | 3,714,940 | reduced | -0.94 | ||
| KYMR | kymera therapeutics inc | 9.46 | 328,743 | 9,812,980 | reduced | -15.43 | ||
| MRUS | merus n v | 8.45 | 148,109 | 8,763,610 | reduced | -41.94 | ||
| RGNX | regenxbio inc | 10.22 | 906,248 | 10,603,100 | unchanged | 0.00 | ||
| RPTX | repare therapeutics inc | 3.04 | 956,932 | 3,157,880 | added | 51.11 | ||
| STRO | sutro biopharma inc | 2.15 | 762,498 | 2,234,120 | reduced | -34.58 | ||
| silence therapeutics plc | 9.16 | 500,214 | 9,504,070 | reduced | -12.89 | |||
| immatics n.v | 2.24 | 200,000 | 2,324,000 | new | ||||